Unconventional Coupling between Ligand Recognition and Allosteric Control in the Multidrug Resistance Gene Regulator, BmrR

Abstract

BmrR is a multidrug resistance (MDR) regulator that responds to diverse ligands. To obtain insight into signal recognition, allosteric control, and cooperativity, we used a quantitative in vitro transcription assay to determine the ligand-dependent activation profiles for a diverse set of cations, zwitterions, and uncharged ligands. As for many other biological switch systems, the data are well described by a modified Hill equation. Parameters extracted from curve fits to the data include L , R and N. We found that L values correlate directly with ΔG values, suggesting that the parameter reflects binding, whereas R and N reflect allosteric control and cooperativity, respectively. Our results suggest unconventional coupling between ligand binding and allosteric control, with weakly interacting ligands exhibiting the highest levels of activation. Such properties are in stark contrast to those often exhibited by biological switch proteins, whereby ligand binding and allostery are tightly coupled, yielding both high selectivity and ultrasensitivity. We propose that weakened coupling, as observed for BmrR, may be important for providing robust activation responses to unrelated ligands. We also propose that other MDR proteins and other polyspecific switch systems will show similar features.

Molecular insights into antibiotic resistance - how a binding protein traps albicidin

“…The observed positive cooperativity with Hill coefficients n of 2.0–3.0 is in agreement with a binding process that includes recruitment of albicidin to one domain favoring subsequent association to the neighboring domain. Such a cooperative binding behavior has been also observed for the MerR protein BmrR 35 . The strong binding of albicidin consequently leads to a well-defined NTD-CTD arrangement in AlbAS causing an increase in thermal stability, Δ T m , of about 15 °C.…”

Cancer resistance to treatment and antiresistance tools offered by multimodal multifunctional nanoparticles

“…Thus, usually, tumoural cells are resistant to drugs of a wide chemical variety, what is known as multidrug resistance (MDR) from where over 90% of cancer treatment failures have been attributed to (Gong et al 2012 ; Luqmani 2005 ). Note that the list of mechanisms mentioned above that induce the appearance of drug resistance and MDR is not exhaustive and new studies of drug resistance mechanisms are constantly appearing, as well as the complex and challenging ways in overcoming this type of multidrug treatment resistance (Bachas et al 2017 ; Dlugosz and Janecka 2016 ; Gao et al 2015a , b ; Higgins 2007 ; Noll et al 2017 ).…”